Our Foundation
Our company was founded in 2008 out of a research collaboration between Dr. Larry DeLucas (Biochemistry Professor at the University of Alabama at Birmingham, also an Astronaut) and Dr. Bill Wilson (Emeritus Chemistry Professor at the Mississippi State University). Through several STTR grants, the team successfully developed an automated and high-throughput process to effectively screen thousands of formulations to enhance protein stability in a solution in a short period of time.
Our Technology
Our high-throughput method utilizes self-interaction chromatography (SIC) technique to measure the second virial coefficient, B22, a thermodynamic value of protein-protein interactions in a solution. Using this technology, our company can screen up to 40 pharmaceutical excipients in 2-4 week time frame, while only consuming as little as 30 mg of precious biologics.
Our Achievements and Capabilities
Since its inception, our company has completed over 30 commercial projects, as well as several academic collaborators. In the past few years our company has also expanded our services to provide a comprehensive service to our customers’ needs, from protein expression, formulation, analytical development, stability studies, to manufacturing capabilities to support phase 1 clinical studies.
Let’s work together!
Build a project with us!